Antipsychotics for BPD: Benefits, Risks and Review

32 Min Read
32 Min Read
Woman in gardener clothing with hands at her temples beside the headline BPD and antipsychotics.
Understand the purpose of an antipsychotic prescription and weigh its benefit against its burden.

Antipsychotics are prescription medicines sometimes offered to people with borderline personality disorder (BPD), but they are not a proven treatment for its core difficulties. Their possible role depends on the reason for prescribing: a carefully reviewed, limited addition for a specific symptom is different from treatment for a separate condition such as bipolar disorder or schizophrenia. The useful question is what the medicine is meant to change, whether that change helps everyday life, and whether its burdens justify continuing it.

A quieter evening does not automatically mean a better treatment result. Someone may feel less distressed and more able to take part in therapy, or they may simply feel too sleepy to do much. Those outcomes need different responses, even if both look like “calming down” from the outside.

If you already take an antipsychotic, this article is a way to understand and discuss the prescription, not a reason to stop or adjust it yourself. If there is an overdose, difficulty breathing, collapse, a high temperature with severe muscle stiffness or confusion, or an immediate inability to stay safe, seek emergency care now rather than waiting for a routine medication review. Bring the medicine packaging if it is readily available, without delaying help.

Why might someone with BPD receive an antipsychotic?

The name of the drug class does not tell you why it was prescribed. Antipsychotics have different uses, and receiving one does not by itself establish that you have psychosis, bipolar disorder or any other diagnosis. Ask for the actual indication in plain language: the condition or particular problem the prescription is intended to address.

For BPD itself, structured psychotherapy is the foundation of treatment. Medicines do not teach the skills involved in handling relationship conflict, tolerating difficult emotions or building a more stable sense of self. A treatment plan can address immediate distress while still protecting access to the work that targets those longer-standing difficulties.

The American Psychiatric Association’s BPD treatment guidance favors psychotherapy and a narrow role for medication: a defined symptom, a limited period and review alongside psychological treatment. Its recommendation to review medicines at least every six months is not permission to leave a new problem or troublesome side effect unattended until then.

NICE takes a more restrictive position. Its BPD recommendations on drug treatment advise against medication specifically for BPD or its individual symptoms, and against medium- or long-term antipsychotic treatment for BPD. These recommendations should not be blended into a claim that routine ongoing antipsychotic treatment is standard care for the disorder.

The reason for prescribing changes the decision
Prescription purposeWhat the discussion needs to establish
Core BPD difficultiesStructured psychotherapy targets the central difficulties. Do not assume an antipsychotic treats the disorder as a whole.
A particular symptom within BPDWhere a clinician proposes an adjunctive trial, ask for the target, uncertainty, review point and role of psychotherapy. NICE is more restrictive about this use.
Another diagnosed conditionClarify the separate indication and its treatment plan. BPD does not rule out another condition that needs medication.
An old prescription with an unclear purposeReview the history and current benefit before deciding about continuation; do not abruptly stop it yourself.

Separate the diagnosis from the immediate target

A clinician may describe a proposed prescription as an adjunct, meaning an addition to the main treatment rather than its replacement. That word is only useful when the added job is clear. “Help with everything” leaves no fair way to decide whether the medicine succeeded, while a specific symptom allows a more honest discussion of benefit and harm.

A person can also have BPD and another condition that needs medication in its own right. For example, the reasons for using an antipsychotic in a diagnosed manic episode differ from the reasons for a short trial aimed at distress occurring within BPD. The separate guide to BPD and bipolar disorder patterns explains why the surrounding course, sleep and energy changes matter; a medicine name cannot settle that distinction.

This difference becomes especially important when a prescription has continued for years. A warning against long-term antipsychotic use for BPD does not automatically mean that every long-term prescription in a person with BPD is inappropriate. The prescription may be treating another illness. The review must establish the original reason and the current reason before anyone draws conclusions about continuation.

Off-label does not mean evidence-free or evidence-proven

Off-label prescribing means using a medicine outside the particular indication, age group, formulation or other terms covered by its license in that jurisdiction. It can occur in legitimate clinical care, but the label does not prove that the treatment is effective for BPD. Equally, an off-label prescription is not automatically a prescribing error. The explanation still needs an expected benefit, relevant uncertainty, alternatives and a safety plan.

Ask whether the proposed use is licensed where you live and what supports it for your situation. A drug’s approval for schizophrenia or bipolar disorder cannot be transferred into an approval for BPD merely because some symptoms sound similar. Licensing also differs between countries, so a brand’s status elsewhere is not a substitute for the local product information.

You should be able to describe the plan without having to defend the diagnosis or justify being distressed. A useful starting sentence is: “I understand this medicine is intended to help this particular problem; what change would show it is helping, and when will we decide?” If the answer is still vague, clarifying the purpose is more useful than comparing brand names.

Illustration of a woman pointing to three prescription purposes: BPD difficulties, a specific symptom and another condition.

Clarify whether the plan addresses core BPD difficulties, a specific symptom or another condition.

How can you judge possible benefit without mistaking sedation for recovery?

Begin with the problem that mattered before the prescription, then ask whether it has changed in a way you value. Sleep, visible activity and emotional expression can all change without the original difficulty improving. A treatment judgment should include what you can do, how you feel and what has become harder, rather than relying entirely on someone else’s impression that you look calmer.

There is no reliable league table identifying one antipsychotic as the best treatment for BPD. Research into medication for the disorder has not established a consistent improvement in its core pathology. The Cochrane review of medicines for BPD found substantial uncertainty, including very low-certainty evidence for overall symptom severity. A small change in a research rating cannot be assumed to mean a worthwhile improvement for every individual.

That uncertainty has a practical consequence: avoid treating an open-ended prescription as a treatment success by default. Continuing because nothing has been reviewed is different from continuing because there is a clearly understood benefit. On the other hand, a broad research result cannot tell an individual to stop a medicine that may be addressing a separate illness or a particular clinical need.

Compare an observable target with an everyday capability

For a planned discussion, choose one concrete example of the intended change and one ordinary activity that matters to you. You do not need to create a symptom diary, score yourself or reconstruct exact dates. Use what you can reasonably remember, and say when you are unsure. If a clinician needs a formal measure, that can be completed with support rather than becoming a condition for having your concerns heard.

For example, someone might want distressing suspicious thoughts to interfere less with conversations, while also wanting enough alertness to follow what another person says. The question is not whether the person has become more agreeable. It is whether the intended difficulty is less intrusive while their ability to participate is maintained or improved. This is an illustrative comparison, not a promise that an antipsychotic will produce that result.

Describe the burden with equal specificity. “I feel bad” can be hard to interpret; “I struggle to stay awake through breakfast” identifies a problem in daily function. A person can experience a useful change and an unacceptable adverse effect at the same time. The review does not have to force the experience into a simple success-or-failure answer.

Why “atypical” is not a safety guarantee

First-generation and second-generation antipsychotics are broad categories, not a ranking from worse to better. Medicines differ in their effects on alertness, movement, appetite, metabolism and other body systems; individual responses differ too. A lower risk of one problem does not mean a medicine has no important risks, and a low dose does not remove the need for an explanation and follow-up.

The following questions make the benefit discussion more concrete without asking you to test yourself. Use them verbally at a review, with a trusted person if you want support. They are prompts for shared understanding, not a validated assessment, a medication selection method or instructions to change treatment.

  • What exact difficulty was this prescription meant to address?
  • What can I do more easily now, and what has become harder?
  • Could sleepiness, restlessness or another adverse effect be confusing the picture?
  • What would make us continue, reconsider or plan a supervised reduction?
Examples of antipsychotic burdens to discuss, not a drug ranking
Medicine exampleSpecific concerns worth discussing
QuetiapineDrowsiness, dizziness, constipation and weight gain can affect daily life. Ask how safety and physical health will be checked.
OlanzapineSleepiness, increased appetite or weight, and blood-sugar or cholesterol changes can matter even when a person feels calmer.
AripiprazoleRestlessness and new or unusually strong compulsive urges are important to raise. It is not automatically free of sedation or metabolic concerns.
RisperidoneMovement difficulties and hormonal symptoms can be relevant. Report new involuntary movements, breast changes or other troublesome effects.

The examples in this comparison are not recommendations to start one medicine or switch from another. The relevant choice depends on the indication, previous response, other medicines and individual risks. Medicine-specific guidance, such as the quetiapine patient information, and the prescribing plan matter more than a class label or an online list of “best BPD drugs.”

Illustrative comparison of a woman engaged in conversation and the same woman sleepy at a table.

Less visible distress is useful only when the change also makes sense alongside alertness and daily function.

An illustrative example: fewer arguments, less participation

Consider a hypothetical person whose family reports fewer evening arguments after a medication change. The person says they now fall asleep during conversation and have missed an activity they wanted to attend. The change in visible conflict is real, but it does not answer whether distress has improved, whether the medicine caused the change or whether its overall effect is worthwhile.

A useful review would separate the observations. Did the original distress lessen? Was the person able to use their therapy skills? Did daytime alertness deteriorate? Were there other changes, such as a quieter week or less contact with the stressful situation? The point is to avoid giving the medicine credit for every improvement and overlooking every burden.

The next decision belongs in the prescribing conversation. It may involve a different explanation of the problem, a closer look at adverse effects or a revised treatment plan. It should not become an instruction from a relative to take extra tablets to stay calm, or from an online article to skip doses to prove that the medicine is responsible.

Which changes need attention as possible side effects?

New symptoms after starting a medicine or changing its dose deserve an explanation, even when similar symptoms can occur with the underlying condition. Timing is useful information, but it does not establish causation. An assessment may need to consider the medicine, other substances, sleep, physical illness and the original mental-health problem together.

Separate routine concerns from urgent problems. Persistent sleepiness, appetite changes, constipation or sexual difficulties are valid reasons for a medication discussion; severe or rapidly worsening symptoms may need faster assessment. Do not dismiss a physical complaint as “just BPD,” and do not assume that every uncomfortable sensation is a dangerous reaction.

New inner restlessness is not simply a need to calm down

Akathisia is a possible medication-related problem involving an uncomfortable drive to move. Someone may pace, shift their legs or find sitting still extremely difficult, and the experience can be mistaken for ordinary anxiety or agitation. There are other causes of restlessness, so the useful first step is to describe the sensation and its timing rather than diagnose it yourself.

Say, for example: “Since the medicine changed, I feel driven to keep moving and cannot settle in a chair.” Mention whether this is new, whether it affects the whole day and whether you feel safe. You do not have to force yourself to sit still to demonstrate the problem. Promptly contact the prescriber or pharmacist; severe distress, new self-harm thoughts or an inability to stay safe require urgent help.

Do not take an extra as-needed dose to “calm” new restlessness unless that response is specifically part of your prescribed plan and has been checked for this situation. If the symptom is an adverse effect, treating it as proof that the illness needs more medication can lead the discussion in the wrong direction. A clear description lets the clinician assess that possibility.

Illustration of a restless seated woman and a conversation about symptoms beginning after a medicine change.

Explain the urge to move and its timing so a possible medication side effect can be assessed promptly.

Dizziness: reduce the immediate fall risk

Some antipsychotics can cause dizziness, including when standing up. The NHS guidance on olanzapine side effects advises getting up slowly and steadying yourself if dizziness occurs. The immediate aim is to prevent a fall, not to train your balance or prove that you can push through the sensation.

If you are sitting and feel unsteady, stay seated until you feel steady. When you need to rise, do so slowly using a stable support such as fixed chair armrests; if dizziness returns, sit back down safely. Ask for help if you cannot stand safely. Do not use a wheeled chair, a loose plant stand or another object that can move as your support.

If standing is already difficult because of pain or limited mobility, avoid trying a new maneuver alone. Use the assistance or transfer method already appropriate for you. Recurrent dizziness needs a medicine and physical-health review; fainting, chest pain, severe breathlessness, injury or severe ongoing symptoms call for urgent assessment rather than repeated attempts to stand.

Three-panel illustration showing staying seated, rising slowly with chair support and sitting back if dizzy.

Reduce fall risk: stay seated until steady, rise slowly with stable support and sit back if dizziness returns.

Sleepiness can change the safety of a familiar task

If a medicine leaves you sleepy, dizzy or with blurred vision, avoid driving, cycling, tools and machinery until those effects have cleared. Familiarity with the task does not make impairment harmless. For someone who gardens, this includes power equipment and ladder work; it is a task-safety point, not advice to stop all ordinary enjoyable activity.

Do not use extra caffeine or a cold shower as proof that it is safe to drive, and do not move doses around independently to fit a work shift. Tell the prescriber what the task requires and when the impairment occurs. A treatment plan that repeatedly prevents essential work or caring responsibilities needs to acknowledge that cost rather than describing it only as a minor inconvenience.

Movement, hormonal and impulse-control changes

Report new uncontrolled twitching, jerking, shaking or stiffness promptly. These changes need clinical interpretation and should not be concealed out of embarrassment. The risperidone side-effect information also describes possible hormonal effects, including breast changes. Sexual difficulties, changes in menstruation or breast symptoms are legitimate medication concerns, not subjects you must wait to mention until someone asks.

Aripiprazole has a particular warning about new or unusually strong compulsive urges, including gambling, shopping, eating or sexual behavior. These problems can also have other explanations, including the underlying condition. A marked change after a medicine change should be raised promptly rather than attributed automatically to personality or poor judgment. The aripiprazole patient information explains this warning and other important adverse effects.

A relative can help by describing a specific observed change without taking over the person’s choices. “The spending urges became much stronger after the prescription changed” is more useful than “You are irresponsible.” If there is immediate financial vulnerability, practical support can be discussed with the person’s agreement while the medical concern is assessed. Such support does not establish that the medicine caused the behavior.

Recognize the situations that cannot wait

A high temperature together with marked muscle stiffness, sweating, confusion or severe illness can signal a serious reaction, including neuroleptic malignant syndrome. Breathing difficulty, throat or tongue swelling, collapse, a seizure or chest pain with breathlessness also need emergency attention. These examples are not a complete safety checklist: use the medicine leaflet and urgent-care services when a symptom is severe or rapidly worsening.

If you have taken more than prescribed, seek urgent medical advice immediately, even if you currently feel well. Do not drive yourself if impaired, and do not wait for a routine appointment or for this article to identify the exact reaction. Tell the emergency team what was taken, approximately when, and what other medicines or substances may be involved if you know.

What should a useful medication review actually resolve?

A review should leave the purpose, benefit, burden and next decision clearer. It is more than issuing another prescription or asking whether everything is “fine.” You can take part without completing a workbook: bring the medicines themselves when practical, describe a concrete benefit or difficulty, and ask who is responsible for the next step.

Bring the real packaging to clarify what you take

Before a planned appointment, gather your current prescription packets, as-needed medicines and relevant over-the-counter products or supplements in their original labeled containers. Bring them together in a suitable bag if safe and practical. Do not remove pills from their packaging, combine loose tablets or leave medicines accessible to children or anyone at risk while gathering them.

At the appointment, show each packet and explain how you actually take it, including medicines you rarely use or have stopped taking. Ask the clinician or pharmacist to reconcile this with the current prescription record. The purpose is to find discrepancies or interactions, not to decide on your own that two similar-looking tablets are interchangeable.

If carrying everything is impractical, ask the pharmacy or care team to check the dispensing record with you. A trusted person may help with your agreement. An old packet can be useful for identifying a previous prescription, but clearly say it is no longer current. The successful result is an agreed understanding of the medicines in use; it is not a bag full of unidentified pills or a new recording task.

Three-panel illustration of gathering medicine packets, keeping labels attached and showing them to a pharmacist.

Use original labeled packaging to clarify what you actually take, including as-needed medicines and supplements.

Ask which physical-health checks belong to this prescription

A person can feel emotionally steadier while a medicine affects their physical health. Weight, blood pressure, blood glucose and blood lipids may therefore be relevant checks, alongside questions about movement, sedation and other symptoms. The exact plan depends on the medicine, duration, personal risks and local guidance; no single blood test measures whether BPD itself is improving.

The NICE antipsychotic monitoring recommendations describe baseline and ongoing checks in psychosis and schizophrenia care. They are useful context for understanding medication safety, not a BPD-specific schedule that every reader should copy. Ask which checks apply to your prescription, when they are due and which service will interpret and act on the results.

You do not need to buy a blood-pressure monitor, weigh yourself repeatedly or interpret laboratory numbers to make this conversation useful. If a check has been missed, ask the responsible service to arrange it. If tests are hard because of needle anxiety, mobility, cost or appointment access, explain that obstacle so the care team can discuss an appropriate adaptation rather than silently abandoning the check.

Illustration of an upper-arm blood-pressure check with labels for weight, blood tests, movement and side effects.

Ask which physical-health checks apply, when they are due and who will follow up the results.

Agree the decision point before a trial becomes indefinite

For a proposed symptom-targeted trial, ask what would justify continuing, when benefit and adverse effects will be reviewed, and who to contact if a problem develops earlier. The duration should come from the prescribing plan, not a generic number on a website. A trial without a decision point can drift into long-term treatment without anyone deliberately deciding that the balance remains worthwhile.

If the medicine has already continued for a long time, ask whether its current indication still matches the original reason. Explain what you believe it helps and what it costs you. Uncertainty is worth saying aloud: “I do not know whether this still helps” gives the review a real question to resolve. It is not a request to make an abrupt change that day.

If reduction or stopping is appropriate, the prescriber should explain the plan, likely difficulties, follow-up and what would require faster help. Withdrawal symptoms and returning illness can be difficult to distinguish, which is one reason a self-designed stop-start experiment is unhelpful. Do not share tablets, copy someone else’s taper or use this article to calculate a reduction schedule.

When a prescription is for another ongoing condition, the review may support continuing it. That outcome can still be a useful review if the indication, monitoring and benefits are clear. The aim is appropriate treatment with informed participation, not stopping medication as an achievement in itself or keeping every medicine simply because it was once prescribed.

Illustration of a medication discussion with four prompts for purpose, benefit and burden, review point and supervised changes.

Leave the review knowing the purpose, the benefit and burden, the decision point and who guides any changes.

Keep the medicine decision connected to the rest of care

Medication review should not become a substitute for access to structured psychological treatment. If therapy has not been offered or is difficult to access, ask what BPD-focused support is available, what the waiting arrangements are and what support exists in the meantime. A prescription can be issued quickly; that convenience does not make it an equivalent replacement for the treatment that addresses core difficulties.

If depression continues alongside BPD, it also deserves attention rather than being assumed to be part of one undifferentiated problem. Here, the narrower question is which difficulty each part of the care plan is intended to address, so that adding a medicine does not leave the central problem untouched.

A practical end to the appointment is a shared verbal explanation: “This is what the medicine is for, this is the benefit we are looking for, these are the concerns, and this is the next review.” Ask for the care team’s accessible written instructions if you need them, but you do not have to create your own tracking system. If an interpreter, supporter or different information format would help, request it as part of care.

Questions about an existing prescription

Does receiving an antipsychotic mean my clinician thinks I have schizophrenia?

No. A drug class has more than one use, and the prescription alone cannot establish a diagnosis. Ask what indication is recorded and whether the medicine is intended for BPD-related distress or a separate condition. You can request an explanation of any diagnostic uncertainty without assuming that the drug name supplies the answer.

Can I stop a low dose without a reduction plan?

A low dose does not tell you whether abrupt stopping is suitable. The medicine, how long you have taken it, the indication and your previous experience all matter. Ask the prescriber for an individual plan rather than skipping doses or using another person's schedule. If you suspect a serious reaction, seek urgent care instead of trying to manage it through a routine taper discussion.

Does taking a medicine only when needed remove its risks?

No. As-needed use still needs a clear indication and instructions about when it is appropriate, the prescribed limits and what to do if it does not help. Tell the care team how often you actually use it and about other sedating products or alcohol. Repeated reliance on an as-needed prescription is a reason to revisit the overall plan, not to invent a new dosing routine.

What if the medicine helps but I dislike how I feel on it?

Both observations belong in the decision. Describe the specific improvement and the specific burden rather than feeling obliged to choose between gratitude and concern. A review can consider whether the balance remains acceptable and what alternatives fit the indication. Do not assume that a worthwhile benefit makes every adverse effect unavoidable.

Can a relative join the review without speaking for me?

Yes, if you want that support and the service can arrange it. Agree beforehand which observations the relative can contribute and which questions you want to answer yourself. You can ask for part of the conversation alone. Useful support clarifies the experience and preserves your participation; it does not turn becoming quieter or easier to manage into the sole treatment goal.

The decision to take forward

For a routine review, start with the part of the prescription you cannot currently explain: its purpose, its effect on daily life, its physical-health checks or its intended duration. Resolve that specific uncertainty before comparing additional medicines. A useful plan makes room for both symptom relief and a life you can participate in, while preserving the treatment and safety support your situation requires.

ExpertsGuys Health Desk is responsible for researching, reviewing, and publishing health and wellness content on ExpertsGuys. The team focuses on evidence-informed topics including nutrition, digestion, metabolism, lifestyle health, and preventive wellness. All articles are written for general educational purposes, with an emphasis on clarity, balance, and practical understanding. Content published by the Health Desk is developed through structured research, reputable sources, and editorial review to support informed health awareness without replacing professional medical advice.
Article link copied